Stocklytics Platform
Asset logo for symbol NRXPW
NRx Pharmaceuticals
NRXPW33
$0.06arrow_drop_down8.04%-$0.00
Penny Stock
Asset logo for symbol NRXPW
NRXPW33

$0.06

arrow_drop_down8.04%

Performance History

Chart placeholder
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About NRx Pharmaceuticals (NRXPW)

NRx Pharmaceuticals, Inc. is a pharmaceutical company that focuses on the development and commercialization of innovative therapies for neurological disorders. The company's stock ticker symbol is NRXPW. NRx Pharmaceuticals is committed to advancing therapies that have the potential to transform the lives of patients suffering from devastating diseases. The company's mission is to accelerate the development of treatments for neurological disorders through innovative research and strategic collaborations. NRx Pharmaceuticals aims to bring new hope to patients and their families by addressing unmet medical needs in the field of neurology.
As of the latest available data, the stock price for NRx Pharmaceuticals, Inc. (NRXPW) is not specified. Investors are encouraged to consult reliable financial sources for the most up-to-date information on the stock price. NRx Pharmaceuticals is a publicly traded company, and its stock price can fluctuate based on various factors such as market conditions, company performance, and investor sentiment.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Stephen H. Willard Esq.
Headquarters
Wilmington
Employees
0
Exchange
NASDAQ
add NRx Pharmaceuticals to watchlist

Keep an eye on NRx Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is NRx Pharmaceuticals's (NRXPW) price per share?

The current price per share for NRx Pharmaceuticals (NRXPW) is $0.06. The stock has seen a price change of -$0.01 recently, indicating a -8.05% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for NRx Pharmaceuticals (NRXPW)?

For NRx Pharmaceuticals (NRXPW), the 52-week high is $0.39, which is 509.38% from the current price. The 52-week low is $0.05, the current price is 36.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is NRx Pharmaceuticals (NRXPW) a growth stock?

NRx Pharmaceuticals (NRXPW) has shown an average price growth of 0.41% over the past three years. It has received a score of 15 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NRx Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is NRx Pharmaceuticals (NRXPW) stock price performance year to date (YTD)?

As of the latest data, NRx Pharmaceuticals (NRXPW) has a year-to-date price change of -67.59%. Over the past month, the stock has experienced a price change of -22.42%. Over the last three months, the change has been -30.43%. Over the past six months, the figure is -57.36%.
help

Is NRx Pharmaceuticals (NRXPW) a profitable company?

NRx Pharmaceuticals (NRXPW) has a net income of -$30.15M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$27.59M. Furthermore, the EBITDA is -$23.26M.
help

What is the market capitalization of NRx Pharmaceuticals (NRXPW)?

NRx Pharmaceuticals (NRXPW) has a market capitalization of . The average daily trading volume is 6.78K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media